Five Prime Therapeutics

Asco 2019 event analyser – low-key meeting belies some huge stock moves

Mirati Therapeutics nearly stole the show at Asco despite not actually presenting – a fact that illustrates how low on meaningful data this year's conference was.

January 16, 2019

Five Prime moves towards subprime

October 17, 2018

Pre-Esmo jitters for Roche

Discontinuations and an unusual revelation about Tecentriq’s breast cancer data dominated the R&D part of the company’s third-quarter results call.

November 28, 2017

Immuno-oncology combos – what will be hot in 2018?

November 08, 2017

“Surprise” SITC late-breaker breaks Five Prime

October 26, 2017

SITC preview – All eyes on Incyte and Infinity

October 10, 2017

Merck’s CTLA4 move – insurance policy or knockout bid?

March 31, 2017

AACR – Combinations, oncolytic viruses and more

March 31, 2017

AACR – Combinations, oncolytic viruses and more

November 28, 2016

Returns hint at gradual decline in quality of biotech floats

March 18, 2016

AACR preview – Novel targets in the spotlight

Load More